GNVC should be a case study on the first page of the biotech trader's handbook.
I forget the name of the drug, but the study was in pancreatic cancer. Seemed like it was going well then one night, WHAAMO!! total failure and the drug was being yanked. That was horrible.
I remember watching the videos on you tube and seeing those poor people who were looking to get it for compassionate use. Puts our loss in perspective. I think it's important to remind myself that these drugs mean a lot more to some than just a big shot in a brokerage account.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.